// App-Quantinova.ai

4870 : A novel potential target for cancer immunotherapy

Researchers

Presenter

  • Susanna Campagnoli

Principal Investigators

  • Matteo Parri

  • Alberto Grandi

  • Elisa De Camilli

  • Giuseppe Viale

  • Renata Maria Grifantini

  • Piero Pileri

Medical Centers

  • Externautics SpA, Siena, Italy

  • European Institute of Oncology, Milan, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Programmed cell death 1 ligand 2

  • Programmed cell death protein 1

  • Programmed death-ligand 1

  • Cytotoxic T-lymphocyte-associated protein 4

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A